Stock Events

Ultragenyx Pharmaceutical (0LIF.LSE) Q4 2024 Earnings

29OctConfirmed
Q1 2024
Q2 2024
Q3 2024
Next
-2.03
-1.84
-1.65
-1.47

Details

Expected EPS
-1.465294
Actual EPS
N/A
Surprise EPS
1.47
Surprise Percent
+100%

Description

Ultragenyx Pharmaceutical (0LIF.LSE) will report earnings of for Q4 2024 on October 29, 2024.

0 Comments

Share your thoughts